This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Mingle Metal (Shen Zhen) Co. Limited, Athenex Hk Innovative Limited, Health Hope Pharma Ltd. Active years: 2008-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 4 
1 out of 7 
1 out of 2 Years Active: 2008-2024
Title: **Ming Tsung Lee: Innovator in Pharmaceutical Compositions**
Introduction
Ming Tsung Lee is a prominent inventor based in Hong Kong, CN, recognized for his significant contributions to pharmaceutical innovations. With a total of 5 patents to his name, Lee focuses on enhancing drug compositions to improve absorption and efficacy. His work reflects the integration of scientific research with practical medication applications.
Latest Patents
Among Lee's latest patents is one entitled "Oral Taxane Compositions and Methods." This invention describes a pharmaceutical composition consisting of various taxanes, including paclitaxel and docetaxel, combined in a mixture of first and second surfactants. The innovative aspect of this composition lies in its ability to significantly increase the absorption of docetaxel, surpassing that of the individual surfactants. The optimal ratio of surfactants in the composition is between 60:40 and 85:15 by weight, ensuring the total surfactant weight remains below 98% of the overall weight. Suitable first surfactants include Polysorbate 80 and 20, while the second surfactants are Polysorbate 80 or polyethyoxylated castor oil. Additionally, the stability of this pharmaceutical composition can be further enhanced with the incorporation of stabilizers like citric acid and ascorbic acid.
Career Highlights
Throughout his career, Ming Tsung Lee has made notable strides in his field, particularly through his work at notable companies such as Mingle Metal (Shenzhen) Co. Limited and Athenex HK Innovative Limited. His experience in these organizations has provided him with a robust foundation to spearhead innovations in pharmaceutical compositions.
Collaborations
Lee has had the opportunity to collaborate with esteemed colleagues, such as Waiming Ho and Denise S. B. Chan. These collaborations have likely fostered a dynamic environment in which innovative ideas are developed and refined, contributing to the evolution of pharmaceutical sciences.
Conclusion
Ming Tsung Lee stands out as a key contributor to the advancement of drug formulations aimed at improving patient outcomes. His focus on pharmaceutical compositions, underpinned by his latest patents, showcases his commitment to innovation in the healthcare sector. As he continues to build on his legacy of inventions, the impact of his work is poised to resonate within the realms of pharmaceuticals and medical research for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile